DZ Bank AG restated their sell rating on shares of STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) (NASDAQ:STDAF) in a research note issued to investors on Friday morning.

Shares of STADA ARZNEIMITTEL NP (NASDAQ STDAF) opened at 76.05 on Friday. STADA ARZNEIMITTEL NP has a 1-year low of $45.80 and a 1-year high of $76.05. The stock has a market capitalization of $4.73 billion and a PE ratio of 42.75. The stock has a 50 day moving average price of $74.85 and a 200-day moving average price of $67.68.

COPYRIGHT VIOLATION WARNING: This story was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another publication, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The correct version of this story can be read at https://www.thecerbatgem.com/2017/08/21/stada-arzneimittel-npvregd-vinkulierts-stdaf-sell-rating-reiterated-at-dz-bank-ag.html.

Receive News & Stock Ratings for STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) and related stocks with our FREE daily email newsletter.